Aeglea Biotherapeutics — 1 Year Data from First in Human Study of Pegzilarginase for the Treatment of Arginase 1 Deficiency (ARG1-D) · Slide 7
Aeglea Biotherapeutics — Redefining the Possible. Human Enzyme Therapies for People with Rare Diseases · Slide 42023
Aeglea Biotherapeutics — Redefining the Possible. Human Enzyme Therapies for People with Rare Diseases · Slide 82023
Aeglea Biotherapeutics — Redefining the Possible. Human Enzyme Therapies for People with Rare Diseases · Slide 102023
Banker Decks
